2 June 2021 00:59
Researches at Airlangga University in Surabaya, East Java answers that the Merah Putih Covid-19 Vaccine entering the first phase of the preclinical test and will be ready to use in early 2022. The team is now preparing for the second phase of the preclinical test.
Streaming